future health semaglutide What if your weight loss medication could do so much more than help you lose weight? 👀 GLP-1 medications like aren't just changing the number on the scale—they're transforming overall FuturHealth | Weight Loss Medication,

Topamax gained FDA approval in 1996 for the treatment of various forms of epilepsy, a neurological disorder characterized by recurrent, uncontrolled seizures

Well, NAD+ (nicotinamide adenine dinucleotide) is, quite simply, indispensable

Most analysts expect a filing in late 2027 at the earliest, with potential approval in 2028

Abstract Background Malignant melanotic nerve sheath tumor (MMNST), formerly called melanotic schwannoma, is a rare tumor of neural crest derivation which most frequently arises from the region of spinal or autonomic nerves near the midline

The FDA has specifically warned that direct-to-consumer marketing cannot imply equivalence with FDA-approved drugs - including through references to "the same active ingredient." This regulatory position applies to every compounded semaglutide program in the market, not to Novi specifically

Now Kennedy is working to undo that with major risks to the public